Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Buy
939
+510
+119% +$59.7K 0.04% 172
2026
Q1
$51.6K Buy
429
+356
+488% +$41.1K 0.02% 173
2025
Q4
$8.28K Buy
73
+46
+170% +$4.32K ﹤0.01% 210
2025
Q3
$2.27K Buy
+27
New +$2.22K ﹤0.01% 162

Other funds holding MRK

E Fund Management (HK)'s MRK Position: Q2 2026 in Review

E Fund Management (HK) increased its Merck (MRK) stake by 119% in Q2 2026, buying an estimated $59.7K and bringing the position to 939 shares worth $121K. The position accounts for 0.04% of the portfolio, ranked #172.

E Fund Management (HK) first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 1,291 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • E Fund Management (HK) held 939 shares of Merck worth $121K as of Q2 2026.
  • E Fund Management (HK) bought 510 Merck shares in Q2 2026, an estimated $59.7K.
  • Merck made up 0.04% of E Fund Management (HK)'s portfolio in Q2 2026, its #172 holding.
  • E Fund Management (HK) first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 1,291 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.